As of 2025-12-16, the Intrinsic Value of Privia Health Group Inc (PRVA) is 35.27 USD. This PRVA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 24.34 USD, the upside of Privia Health Group Inc is 44.90%.
The range of the Intrinsic Value is 21.84 - 134.71 USD
Based on its market price of 24.34 USD and our intrinsic valuation, Privia Health Group Inc (PRVA) is undervalued by 44.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 21.84 - 134.71 | 35.27 | 44.9% |
| DCF (Growth 10y) | 38.29 - 242.54 | 62.67 | 157.5% |
| DCF (EBITDA 5y) | 22.51 - 26.70 | 24.62 | 1.2% |
| DCF (EBITDA 10y) | 34.83 - 43.18 | 38.91 | 59.9% |
| Fair Value | 0.74 - 0.74 | 0.74 | -96.97% |
| P/E | 3.16 - 7.99 | 5.17 | -78.8% |
| EV/EBITDA | 7.94 - 9.40 | 8.81 | -63.8% |
| EPV | 5.20 - 5.64 | 5.42 | -77.7% |
| DDM - Stable | 1.42 - 5.46 | 3.44 | -85.9% |
| DDM - Multi | 13.27 - 40.23 | 20.01 | -17.8% |
| Market Cap (mil) | 2,993.82 |
| Beta | 0.71 |
| Outstanding shares (mil) | 123.00 |
| Enterprise Value (mil) | 2,552.47 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.36% |
| Cost of Debt | 4.48% |
| WACC | 5.72% |